Skip to content

How Does Medical Clown Intervention Affect the Length of Hospitalization in Children With Pneumonia

How Does Medical Clown Intervention Affect the Length of Hospitalization in Children With Pneumonia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06750029
Enrollment
51
Registered
2024-12-27
Start date
2018-10-30
Completion date
2023-11-07
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-Acquired Pneumonia (CAP)

Keywords

Medical clowns, Community-Acquired Pneumonia (CAP)

Brief summary

Background and Objectives: Community-acquired pneumonia (CAP) is a leading cause of hospitalization in children. The hospitalization duration depends on factors as child's well-being, vital signs, need for parenteral treatments, and development of complications. Medical clowns (MCs) are known to assist in reducing pain and alleviating anxiety and have been integrated into many aspects of hospital treatment routines. The aim of this study is to evaluate the effect of MC intervention on length of hospitalization in children admitted with CAP.

Interventions

OTHERMedical clown visits

The intervention is 15-minute visits from MCs twice daily during the first two days of admission. The clowns use various techniques to relax the patients (e.g. music, singing, playing, humor, guided imagination) and helpe encourage children to begin drinking and eating on their own.

Sponsors

Carmel Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
2 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of pneumonia. * Ages 2-18 years.

Exclusion criteria

* Hemodynamically unstable patients. * Other systemic comorbidities or chronic respiratory diseases * Children from families unable to comprehend and sign an informed consent form.

Design outcomes

Primary

MeasureTime frameDescription
The length of hospitalization in hoursImmediately after the interventionThe length of hospitalization in hours is determined by the duration between admission and discharge from the pediatric department.

Secondary

MeasureTime frameDescription
Duration of IV treatmentImmediately after the interventionDuration of IV treatment in hours.

Other

MeasureTime frameDescription
Alterations in body temperatureImmediately after the interventionAlterations in body temperature
Alterations in Respiratory rateImmediately after the interventionAlterations in Respiratory rate
Alterations in oxygen saturationImmediately after the interventionAlterations in oxygen saturation
Changes in well-being scores as reported by both the parent and the treating physician.Immediately after the interventionChanges in well-being scores as reported by both the parent and the treating physician, and alterations in vital signs and laboratory results.
Alterations in absolute neutrophil countImmediately after the interventionAlterations in absolute neutrophil count
Alterations in C-reactive protein levelsImmediately after the interventionAlterations in C-reactive protein levels
Alterations in white blood cell countImmediately after the interventionAlterations in white blood cell count
Alterations in Heart rateImmediately after the interventionAlterations in Heart rate

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026